The present disclosure relates generally to imaging capsules and, more specifically, to activation of imaging capsules with alternating current.
One method for examining the gastrointestinal tract for the existence of polyps and other clinically relevant features that may indicate regarding the potential of cancer is performed by swallowing an imaging capsule that will travel through the tract and view the patient's situation. In a typical case the trip can take between 24-48 hours, after which the imaging capsule exits in the patient's feces. Typically the patient swallows a contrast agent to enhance the imaging ability of the imaging capsule. Then the patient swallows the imaging capsule to examine the gastrointestinal tract while flowing through the contrast agent. The imaging capsule typically includes a radiation source, for example including a radioisotope that emits X-rays or Gamma rays. The radiation is typically collimated to allow it to be controllably directed toward a specific area during the imaging process. In an exemplary case the imaging capsule is designed to measure Compton back-scattering and transmits the measurements (e.g. count rate) to an external analysis device, for example a computer or other dedicated instruments.
In a typical implementation a radio-opaque contrast agent is used so that a position with a polyp will have less contrast agent and will measure a larger back-scattering count. Alternatively, other methods may be used to image the gastrointestinal tract.
U.S. patent application Ser. No. 7,787,926 to Kimchy, the disclosure of which is incorporated herein by reference, describes details related to the manufacture and use of such an imaging capsule.
Use of an imaging capsule requires a power source to be connected to the capsule electronics to supply power to the electronics for operation. If the capsule is stored prior to use with the capsule electronics in an active condition, the electronics may draw power from the batteries and/or experience current leakage. If the power source were to fail, the imaging capsule can malfunction in various ways. For example, if the capsule includes an actuatable shutter for blocking radiation when such radiation is not desired, radiation may be emitted without constraint causing potential harm to the patient.
If the imaging capsule is equipped with an internal switch for activating the capsule electronics, such activation may require access to an interior of the capsule. Such a breach of the capsule could leave the capsule in an unsealed, vulnerable condition for use by a patient.
It may thus be desirable to provide an activation apparatus and method that allow the capsule electronics to be connected to the batteries and remain with no power and no current leakage in a sealed shell while the capsule is in storage and enable activation of the electronics without breaching the capsule shell, thus leaving it sealed.
This disclosure concerns the description of activation mechanisms for activating the electronic circuits of an imaging capsule. The capsule is designed to be swallowed by the patient and travels through the Gastro Intestinal tract. An example of such a concealment mechanism is described in U.S. patent application Ser. No. 10/596,065, filed on May 26, 2006, now U.S. Pat. No. 7,787,926, titled Intra Lumen Imaging Capsule, and PCT Publication No. WO 2012/035528, titled Fail-safe Radiation Concealment Mechanism, the disclosures of which are incorporated herein by reference.
The concealment mechanism is designed with shutters that are normally closed, effectively stopping the emitted radiation from the radiation source within the capsule to exit the capsule, thus reducing the exposure of the patient to ionizing radiation.
When the radiation is emitted and the collimator is moving and scanning, detectors (13) in
The described mechanisms open the shutters only when the capsule requires these photons (or beta electrons) for imaging the internal lumen of the gastro intestinal tract.
According to various aspects of the disclosure, an imaging capsule activating system includes a capsule containing a radiation source, and an arrangement with the radiation source mounted thereon. The arrangement is configured to selectively allow emission of radiation from the radiation source. A blocking arrangement is configured to selectively block emission of radian from the radiation source. In a rest position, the emission of radiation from the arrangement is blocked. A movement arrangement configured to move the blocking arrangement relative to the arrangement. A controller operates the radiation source and the blocking arrangement. An activation coil is electrically coupled with the controller and has an initial configuration without current flow. An external activating coil receives the imaging capsule and is operable to inductively induce current flow in the activation coil within the capsule.
In accordance with the disclosure, a method of activating an imaging capsule includes providing a capsule similar to that described above, disposing the imaging capsule in an open external activating coil, and operating the external activating coil to inductively induce current flow in the activation coil with the capsule.
The present disclosure will be understood and better appreciated from the following detailed description taken in conjunction with the drawings. Identical structures, elements or parts, which appear in more than one figure, are generally labeled with the same or similar number in all the figures in which they appear, wherein:
Reference will now be made in detail to specific embodiments or features, examples of which are illustrated in the accompanying drawings. Generally, corresponding or similar reference numbers will be used, when possible, throughout the drawings to refer to the same or corresponding parts.
Reference is made to
During a typical screening procedure using system 141, an oral contrast agent 170 is administered to subject 154. Contrast agent 170 is typically adapted to pass through a gastrointestinal (GI) tract 172 and be expelled with the feces, substantially without being absorbed into the blood stream. The contrast agent material may be similar to compounds used routinely for the study of the GI with X-rays, such as Barium sulfate liquid concentrate, iodine-based compounds, or other such materials. For some applications, additional appropriate contrast agents include Tantalum, Gadolinium, Thorium, Bismuth, and compounds of these materials. After the contrast agent is administered (e.g., several hours after the contrast agent is administered), subject 154 swallows capsule 150.
Capsule 150 travels through GI tract 172, emitting gamma and/or X-ray radiation. Beginning at a certain point in time, capsule 150 records the Compton scattered gamma and/or X-ray photons that strike one or more radiation detectors 162 (
Reference is now made to
Reference is now made to
In an exemplary embodiment of the invention, a patient first swallows a contrast agent which mixes with the content of their gastrointestinal tract to increase the accuracy of the measurements. Then the patient swallows imaging capsule 100 to examine the gastrointestinal tract as imaging capsule 100 proceeds through the gastrointestinal tract. In an exemplary embodiment of the invention, imaging capsule 100 is designed to automatically block radiation from being emitted from it until receiving instructions to release radiation and image its surroundings. In an exemplary embodiment of the invention, no power is required to prevent blocking emission of radiation. Thus, if imaging capsule 100 lacks power the radiation will be blocked.
In an exemplary embodiment of the invention, imaging capsule 100 includes an encasement 105 for holding and protecting the elements of the device from acids and other liquids or gases along its path of motion. Optionally, the encasement should be able to withstand external pressures for at least 50-100 hours to allow for imaging capsule 100 to traverse the gastrointestinal tract and exit while still intact. Inside encasement 105, imaging device 100 includes a power source 180 (e.g. one or more batteries), a motor 185, a radiation source 110, a detector 195, a transceiver 135, and a controller 199. The controller 199 may be programmed with instructions for operating all the capsule functions, including operation of the transceiver 135. In an exemplary embodiment of the invention, radiation source 110 is located on a rotatable disk 145 and provides radiation that is blocked by a filling material 130 that forms the disk (e.g. made of lead or tungsten or other dense materials). Optionally, the radiation is only free to travel in a few specific directions through collimators 120.
In an exemplary embodiment of the invention, power source 180 provides power to motor 185, motor 185 is configured to rotate disk 145 around a rotation axis 125 with radiation source 110 and collimators 120 mounted on disk 145. In some embodiments, the collimator may be non-rotating, and the motor may be configured to move an arrangement linearly to block/unblock beams emitted from the radiation source and/or non-rotating collimator.
Optionally, one or more directed radiation beams are emitted from collimators 120 controllably scanning the surroundings through imaging capsule 100. Optionally, detector 195 detects backscattered particles resulting from the directed radiation beam. In an exemplary embodiment of the invention, detector 195 counts the detected particles and provides the information to transceiver 135 for transmission to an external device (e.g. a computer) for processing and optionally constructing a visual representation of the information. In some embodiments of the invention, transceiver 135 uses radio frequency (RF) transmissions to receive instructions from an external device and to provide information to the external device. Optionally, the external device may instruct imaging capsule 100 to start scanning, to stop scanning, and/or to scan in a specific motion pattern or at specific times.
It should be appreciated that the radiation source 110 may be adapted to emit gamma rays, X-rays, and/or beta electrons (i.e., radiation having energy of at least 10 keV). For some applications, the radiation source 110 may comprise a radioisotope or a miniature radiation generator. In some aspects of the disclosure, radiation source 110 may comprise a miniature X-ray generator, such as those described in one or more of the following references: U.S. Pat. Nos. 6,134,300 and 6,353,658 to Trebes et al.; Haga, A. et al., “A miniature x-ray tube,” Applied Physics Letters 84(12):2208-2210 (2004); and Gutman, G. et al., “A novel needle-based miniature x-ray generating system,” Phys Med Biol 49:4677-4688 (2004). Such a miniature X-ray generator or X-ray tube may be used for radiation source 110 instead of a radioisotope to illuminate the colon contents with X-ray photons. Turning such a generator on and off as needed typically reduces exposure of the subject to radiation. In addition, the energy range can be better controlled and the flux may be higher for the on periods without increasing subject total exposure. It should be appreciated that the capsule 100 may include more than one radiation source 110. According to various aspects, the capsule 100 may comprise one or more gamma and/or X-ray radiation sources and/or sources of beta electrons, such as T1201, Xe133, Hg197, Yb169, Ga67, Tc99,Tc99m, In111, I131 or Pd100.
Referring now to
Referring now to
Once the load switch 6 is on and the controller 199 is on, the embedded switch in the capsule controller 199 activates all the capsule functions, including operation of the RF transceiver 135, which can then be used to send and receive messages and instructions to and from the capsule 100.
From the foregoing, it will be appreciated that, although specific embodiments have been described herein for purposes of illustration, various modifications or variations may be made without deviating from the spirit or scope of inventive features claimed herein. Other embodiments will be apparent to those skilled in the art from consideration of the specification and figures and practice of the arrangements disclosed herein. It is intended that the specification and disclosed examples be considered as exemplary only, with a true inventive scope and spirit being indicated by the following claims and their equivalents.
This application claims the benefit of U.S. Provisional Patent Application No. 61/802,377, having a filing date of 15 Mar. 2013, which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
61802377 | Mar 2013 | US |